Clinical Trials Directory

Trials / Completed

CompletedNCT00161759

Safety and Efficacy Study of Fibrin Sealant (FS 4IU) for Skin Graft Fixation and Wound Healing in Subjects With Burn Wounds

A Study to Assess the Safety and Efficacy of Fibrin Sealant (FS 4IU) for Wound Healing in Subjects With Burn Wounds Requiring Skin Grafting Procedures

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
40 (planned)
Sponsor
Baxter Healthcare Corporation · Industry
Sex
All
Age
6 Years – 65 Years
Healthy volunteers

Summary

The purpose of this study is to assess if Fibrin Sealant 4IU is as safe and efficacious as staples (the current standard of care) to achieve fixation of skin grafts and wound healing in subjects with burn wounds. Each subject receives staples as well as FS 4IU on comparable treatment sites.

Conditions

Interventions

TypeNameDescription
DRUGSheet skin grafts affixed with Fibrin Sealant (lyophilized) with 4 IU/mL Thrombin

Timeline

Start date
2002-03-01
Completion
2004-01-01
First posted
2005-09-13
Last updated
2006-10-20

Locations

12 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00161759. Inclusion in this directory is not an endorsement.

Safety and Efficacy Study of Fibrin Sealant (FS 4IU) for Skin Graft Fixation and Wound Healing in Subjects With Burn Wou (NCT00161759) · Clinical Trials Directory